Scientists from the University of Kansas (USA) has successfully tested a therapeutic tool against coronavirus. This was reported on the website of the scientific publication Science Daily.

it turned Out that 3C-like protease, 3CLpro is known as, is a major enzyme in the development of SARS-CoV-2. Scientists used found protease inhibitors in mice infected with the MERS coronavirus. The result is aimed at a weak spot of an infectious disease therapeutic agent stopped the replication of the virus.

According to scientists, the armamentarium allows you to block the reproduction of not only MERS, but the coronavirus MERS-CoV and SARS-CoV-2, common among the people. Described in the experiment, the preparations were patented and licensed to, the company, Cocrystal Pharma. Experts said that it is necessary to test the effectiveness of drugs on people.

In July, American scientists have discovered several drugs that could potentially be used against SARS-CoV-2, they are able to suppress the replication of coronavirus in human cells. In particular, is used against hepatitis C boceprevir and antiviral medication GC-376 has demonstrated efficacy against viral protease Mpro, which is crucial to the reproduction of coronavirus.